Mold prompts recall of 5,000 vials of J&J's Risperdal Consta

Johnson & Johnson recalled an estimated 5,000 of the 70,000 vials of antipsychotic drug Risperdal Consta manufactured in one lot last year after testing positive for Alternaria alternata mold during routine quality inspection. The products must be pulled because they remain unused in pharmacies, community mental health centers and doctor's offices.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC